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Background: At present, scientific consensus exists on the multifactorial etiopatogenia of obesity. Both
professionals and researchers agree that treatment must also have a multifactorial approach, including diet, physical
activity, pharmacology and/or surgical treatment. These two last ones should be reserved for those cases of morbid
obesities or in case of failure of the previous ones. The aim of the PRONAF study is to determine what type of
exercise combined with caloric restriction is the most appropriate to be included in overweigth and obesity
intervention programs, and the aim of this paper is to describe the design and the evaluation methods used to
carry out the PRONAF study.
Methods/design: One-hundred nineteen overweight (46 males) and 120 obese (61 males) subjects aged
18–50 years were randomly assigned to a strength training group, an endurance training group, a combined
strength + endurance training group or a diet and physical activity recommendations group. The intervention
period was 22 weeks (in all cases 3 times/wk of training for 22 weeks and 2 weeks for pre and post evaluation). All
subjects followed a hypocaloric diet (25-30% less energy intake than the daily energy expenditure estimated by
accelerometry). 29–34% of the total energy intake came from fat, 14–20% from protein, and 50–55% from
carbohydrates. The mayor outcome variables assesed were, biochemical and inflamatory markers, body
composition, energy balance, physical fitness, nutritional habits, genetic profile and quality of life. 180 (75.3%)
subjects finished the study, with a dropout rate of 24.7%. Dropout reasons included: personal reasons 17 (28.8%),
low adherence to exercise 3 (5.1%), low adherence to diet 6 (10.2%), job change 6 (10.2%), and lost interest
27 (45.8%).
Discussion: Feasibility of the study has been proven, with a low dropout rate which corresponds to the estimated
sample size. Transfer of knowledge is foreseen as a spin-off, in order that overweight and obese subjects can
benefit from the results. The aim is to transfer it to sports centres. Effectiveness on individual health-related
parameter in order to determine the most effective training programme will be analysed in forthcoming
publications.
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The increase in overweight and obesity rates is a major
public health concern. In most countries it has affected
all population groups regardless of sex, age, race, income
or education level, but to varying extents [1]. Based on
comparative studies with other European countries,
Spain is at the forefront [1], one in four people is over-
weight or obese, ie 12.5 million people [2]. In fact, two
out of three men are overweight and one of every six is
obese, with a clear trend to increase in the forthcoming
years [3].
Today it is accepted that obesity has a multifactorial
origin [4,5] and is a known risk factor for numerous
health problems, including high cholesterol, diabetes,
hypertension, respiratory problems, musculoskeletal dis-
eases, cardiovascular diseases, and some forms of cancer.
Mortality also increases sharply once the overweight
threshold is crossed [6,7].
Research has been very active in the last years trying
to identify the most effective treatment for adult over-
weight and obesity [8-40]. A combination of caloric re-
striction with an increase in energy output by means of
exercise has been proven in the hospital setting [41].
Results have been quite conclusive regarding aerobic ex-
ercise [9] and very restrictive caloric intake (less than
50% of kcal intake) [35]. But data are still scarce regard-
ing the effect of a combination of strength and aerobic
training and a much lesser restrictive hypocaloric diet
on weight loss [35]. The PRONAF study wants to get
deeper into the latter, also considering the Consensus
Paper 2011 from the Spanish Society of Obesity Re-
search (SEEDO), that has stated that the primary goal of
treatment should not focus on achieving the ideal body
weight, but to have smaller weight losses maintained in
the long term [42].
Therefore, the main aim of the PRONAF study was to
discover which is the most effective training protocol in
combination with caloric restriction for overweight and
obese subjects included in a specific intervention pro-
gram. The aim of this paper is to describe the design and
the evaluation methods used for the PRONAF study.
Methods/design
Study design
PRONAF is a 22 week-intervention study performed
among Spanish overweight and obese adults, who were
randomly assigned to one of the following intervention
groups: strength training group (S), endurance training
group (E), combined strength plus endurance training
group (SE), and physical activity recommendations group
(C), which are described in detail below. The study was
performed twice, one year apart, first in the overweight
group (year 2009/2010) and then in the obese group
(year 2010/2011). In total, we had 8 interventions groups.Population and sample size estimation
The estimation of the sample size was calculated to de-
tect a main effect of the treatment on the percentage of
body fat with a 80% statistical power at 5% significance,
assuming a 0.80 correlation between repeated measures
[43]. The initial calculated sample size per intervention
group (n = 22) permits the detection of a large effect size
(Cohen’s d = −0.8), as observed in a previous investiga-
tion [43].
The initial adjustment of sample size for dropouts car-
ried out used a maximum of 25% of dropouts in each
group [37]. Adjusted dropouts sample = n (1/1-R), where
n = number of subjects not lost, and R = expected pro-
portion for dropouts. With our data, the initial necessary
sample size was: 88 (1 / 1–0.25) = 118 subjects or 29/30
in each intervention group, this being applicable for both
the overweight and the obese interventions groups. A
total of two hundred thirty nine people initiated the
study, completing it 180 (75.3%), which supposed 59
dropouts for different reasons. For personal reasons 17
(28.8%), low exercise adherence 3 (5.1%), low diet adher-
ence 6 (10.2%), job change 6 (10.2%), and lost interest 27
(45.8%).
Recruitment of the subjects
Subjects were recruited by means of diverse advertise-
ments published in the media and the applicants filtered
using different criteria. The voluntary subjects who ful-
filled the inclusion criteria and passed the baseline phys-
ical examination were stratified by age ranges and body
mass index (BMI), and randomized into the different
intervention groups (Figure 1).
Inclusion and exclusion criteria
Inclusion criteria included being male or female living in
the Region of Madrid, being overweight (BMI 25–
29.9 kg/m2) or obese (BMI: 30–34.9 kg/m2), middle-
aged (from 18 to 50 years), having a sedentary lifestyles
(< 30 min Physical Activity/day), being normoglycaemic,
and non-smoker [37,41]. In the case of females, having
regular menstrual cycles was required.
The exclusion criteria were suffering from a physical
(orthopaedic limitations, stroke, etc.) and/or psycho-
logical (anorexia, bulimia, etc.) disease that may have
precluded the performance of the requested strength or
endurance training, intake of any medication (beta
blockers, alcohol, etc.) known to influence physical per-
formance or the interpretation of the results, having a
history of systematic strength or endurance training
(moderate to high intensity training more than once a
week) in the year before the beginning of the study
[37,40].
After the intervention period, participants who failed
to comply with 90% assistance to the training sessions
Figure 1 Participant flow diagram. S, strength training group; E, endurance training group; SE, combined strength plus endurance training
group; C, physical activity recommendations group.
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from further analysis. The characteristics of the final
sample (completers) are shown in Table 1.
Ethical issues
The protocols and procedures of the PRONAF study
were in agreement with the ethical guidelines on bio-
medical research on human subjects of the World Medical
Association’s Declaration of Helsinki (1964) and furtherTable 1 Baseline data (n = 180)
Overweight n = 8
Women
n = 48
Age (years) 37.29 ± 8.25
Body Weight (kg) 73.5 ± 5.87
Height (m) 1.62 ± 0.06
BMI (kg/m2) 28.01 ± 1.32
Body fat (%) 43.28 ± 3.62
Body fat free mass (kg) 40.25 ± 4.3
Bone mineral density (g/cm2) 1.18 ± 0.1
Results are shown as Mean ± SD.
Note. BMI = Body Mass Index. Body fat, Body fat free mass and Bone mineral densitamendments. Before participating in this research, all
subjects were carefully informed about the possible risks
and benefits of the project, being required to read and
sign an institutionally approved informed consent docu-
ment. PRONAF study was approved by the Human
Research Review Committee of the University Hospital
La Paz (PI-643).
Access to the database was restricted to the researchers
that participated in the PRONAF study. Therefore, the4 Obesity n = 96
Men Women Men
n = 36 n = 48 n = 48
37.42 ± 8.02 39.02 ± 7.74 38.79 ± 7.99
88.21 ± 8.13 88.33 ± 10.1 102.04 ± 8.94
1.75 ± 0.07 1.64 ± 0.07 1.77 ± 0.06
28.57 ± 1.12 32.41 ± 1.85 32.4 ± 1.9
33.8 ± 4.63 47.11 ± 3.49 38.17 ± 4.02
55.99 ± 5.47 44.3 ± 4.71 58.63 ± 8.96
1.26 ± 0.09 1.21 ± 0.11 1.3 ± 0.1
y calculated by Dual-energy x-ray absorptiometry (DXA).
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ered as confidential following current Spanish legislation
regulating personal data protection (Organic Law 15/
1999 and Royal Decree 1720/2007).
This trial was registered at clinical trials.gov as
NCT01116856. http://clinicaltrials.gov/.
Intervention
Time line intervention
The assessments took place for all subjects one week be-
fore and after 22 weeks of intervention. Additionally,
body weight was measured every 15 days, training inten-
sity and physical activity were controlled monthly, and
dietary intake was evaluated every three months.
Exercise protocols
Four different intervention groups were involved in the
study as stated above. The S, E and SE groups followed
the corresponding training program plus the dietary
intervention, and the C group followed the dietary inter-
vention and was instructed about the general recommen-
dations regarding physical activity for weight loss from
the American College of Sports Medicine (ACSM) [44].
Subjects in the S, E and SE groups performed training
3 times/wk for 22 weeks at a Sports Centre in Madrid
(Spain). All training sessions were carefully supervised
by certified personal trainers. The exercise programs
were designed taking into account each subject’s muscle
strength (MS) and the heart rate reserve (HRR). MS was
measured using the 15-repetition maximum (15 RM)
testing method [45] in the S and SE groups (both of
which involved strength training). Both volume and in-
tensity of exercise was increased over the study period
(Figure 2) according to standard procedures [35,41].Figure 2 Time line of the Study. S, strength training group; E, endurance
C, physical activity recommendations group.Prior to each training session each subject started with
a 5-minute aerobic warm-up routine, followed by the
session routine, and concluded with a 5-minute cool
down and stretching exercises routine. Moreover, an
MP3 audio track was played for each participant to set
the execution rhythm of the exercises during all the ses-
sions. In this case, the heart rate (HR) was monitored by
a pulse-meter (Polar RS800CX, Polar Electro, Kempele,
Finland). The cadence for the resistance exercises was
fixed at 1:2 (concentric-eccentric phase). A session rou-
tine consisted in the execution on eight scheduled exer-
cises in the case of group S (i.e., shoulder press, squat,
barbell row, lateral split, bench press, front split, biceps
curl and French press for triceps). Regarding types of
exercises, running, cycling or elliptical (self-selected)
exercises were the main components of the session rou-
tine for group E, while the routine for the SE group con-
sisted in a combination of cycle ergometry, treadmill or
elliptical intercalated with squat, row machine, bench
press and front split.
The volume and intensity of the three training pro-
grams increased progressively. During the adaptation
period (cf. weeks 1–4) subjects were taught on the exer-
cise technique. Between the fifth and eight week, exer-
cises were carried out at an intensity of 50% of 15RM
and HRR, performing 2 laps to the circuit (cf. 51 minutes
and 15 seconds), then between the 9th and 14th week the
intensity was increased up to 60% of 15RM and HRR,
and finally during the period between the 15th and 24th
week the volume increased from 2 to 3 laps to the cir-
cuit (64 minutes). Then, a five-minute recovery period
was set between the circuits. The S and SE participants
performed 15 repetitions (45”) for each exercise with a
rest period of 15 seconds between them.training group; SE, combined strength plus endurance training group;
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Hypocaloric diets (between 5028 and 12570 KJ) were
prescribed individually for all participants by expert die-
ticians at the Department of Nutrition, La Paz University
Hospital, Madrid. The diet was designed to provide 25-
30% less energy than the daily energy expenditure
(DEE), as measured using SenseWear Pro3 Armband™
(Body Media, Pittsburgh, PA). Approximately, 29–34%
of the energy came from fat, 14–18% from protein,
and 50–55% from carbohydrates [46]. In the obesity
group, energy provided from protein was increased up
to 14–20%.
Before-after measurements
Physical fitness and health
Maximal aerobic power test The test was conducted
on a computerized treadmill (H/P/COSMOS 3PW 4.0,
H/P/Cosmos Sports & Medical, Nussdorf-Traunstein,
Germany). Peak oxygen uptake (VO2 peak) was mea-
sured with the modified Bruce protocol used elsewhere
with overweight and obese population [35,47]. Volume
and composition of expired gas was analysed with a gas
analyzer Jaeger Oxycon Pro (Erich Jaeger, Viasys Health-
care, Germany) which validity and reliability has been
demonstrated previously [48,49], and continuous 12-lead
electrocardiographic monitoring. The exercise test was
maintained until exhaustion. The mean of the three
highest measurements was used as VO2 peak. Identical
procedure was carried out to calculate the maximal HR.
Resting metabolic rate
Subjects were asked to refrain from any exercise for at
least 24 h before the test. To assess the resting metabolic
rate (RMR), participants were cited between 7 am to
10 am, after a 9 h overnight fasted period. RMR was
then measured by indirect calorimetry standing up (dur-
ing 11 min) and in a lying position (additional 20 min).
Oxygen uptake (VO2) and carbon dioxide production
(VCO2) were recorded by a gas analyzer Jaeger Oxycon
Pro (Erich Jaeger, Viasys Healthcare, Germany), and rest-
ing heart rate (RHR) was measured using a heart rate
monitor (Polar Electro Oy, Kempele, Finland). All these
parameters were averaged during the last 5 min of the
standing up position and the last 10 min of the lying
position. Oxigen uptake and VCO2 data were used to
calculate RMR according to the formula of Weir [50].
Maximal dynamic strength
Muscle strength was measured with the 15RM testing
method described elsewhere [51] for both strength train-
ing groups S and SE. The 15 RM for each exercise was
tested twice on different days during the evaluationperiods. The intraclass correlation coefficient of reliability
for all the exercises was ICCr = 0,995 and ICCr = 0,994 for
men and women, respectively. All the assessments, the
data collection sessions and the previous trainings were
carried out with the same machines and free weights
(Johnson Health Tech. Iberica, Matrix, Spain).
Static strength (dinamometry)
The general strength index (SI) was calculated using pre-
vious criteria [52]. This method measures leg and arm
strength with respect to body weight via two exercises:
the bench press and squat. The dynamometric strength
index (DSI) was calculated by measuring muscular
strength using a Tecsymp Tkk5002 hand dynamometer
and a Tecsymp Tkk5401 leg and back dynamometer
(Tecsymp, Barcelona, Spain). The DSI value was calcu-
lated as the sum of the values obtained with both appa-
ratuses divided by subject’s body weight.
Physical activity and daily energy expenditure
Habitual physical activity (PA) was assessed with a
SenseWear Pro3 ArmbandTM (Body Media, Pittsburgh,
PA). Subjects were instructed to wear the monitor con-
tinuously for 5 days including weekend days and week-
days following general recommendations [53]. Data was
recorded by 15 min intervals. DEE was calculated using
the Body Media propriety algorithm (Innerview Research
Software Version 6.0).
Energy balance, adherence to diet and exercise
All subjects were instructed to continue their habitual
daily activities as before the intervention period. They
were required to report the kind, duration, and intensity
of any physical activity and the amount of any food
undertaken during the intervention period.
At the beginning of the intervention, negative energy
balance was calculated taking into account the DEE, and
a 3-day food record, in order to decrease the energy in-
take of the diet by a 25-30% during the intervention.
In one hand, adherence to diet was calculated as
the estimated Kcal of the diet divided by the real
Kcal intake in percentage ([estimated kcal of diet/real
Kcal intake] · 100), representing the highest adherence
the value 100%. Higher values mean a higher restric-
tion and viceversa. On the other hand, adherence to
exercise was calculated by the number of sessions com-
pleted in regard to the theoretical sessions ([sessions
performed /total sessions] · 100).
Psychological and eating behavior assessment
Quality of life The impact of overweight and non-
morbid obesity on Health-Related Quality of Life
(HRQL) was assessed using two different questionnaires:
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The EQ-5D, is a self-administered questionnaire capable
of generating a score reflecting a value associated with a
given health status. The EQ-5D™ descriptive system con-
sists of five dimensions: 1. Mobility; 2. Self-care; 3. Usual
activities; 4. Pain/discomfort; 5.Anxiety/depression. Each
dimension has three levels: “level 1: no health problems”,
“level 2: moderate health problems” and “level 3: ex-
treme health problems”. Each unique health state
described by the instrument has an associated 5-digit de-
scriptor ranging from 11111 for perfect health to 33333
for the worst possible state. The resulting descriptive
system defines 243 health states. The instrument also
includes a 20-centimeter visual analogue scale for the
self-assessment of current general health [54].
Short Form-36 Health Survey (SF-36) version 1.4,
valid for the Spanish population was used [55]. This
questionnaire evaluates the individual health status in
two dimensions: functional and emotional. Functional
status is divided in 6 subscales: Physical Functioning
(PF), Role-Physical (RP), Bodily Pain (BP), Vitality
(VT), Social Functioning (SF) and Role-Emotional (RE).
Emotional status includes Mental Health (MH) and
General Health (GH) subscales. Scores on all subscales
range from 0 to 100 (higher scores indicate better
health status) [56].
Eating behaviour At baseline and at the end of the
intervention all food and beverages consumed by the
participants were recorded using a food frequency ques-
tionnaire and a “3-day food and drink record”, validated
for the Spanish population [57]. This recorded all food
and drinks consumed at home and away for three days,
including 2 weekdays and 1 weekend day. Subjects were
instructed to record the weights of food consumed if
possible and to use household measurements (spoonfuls,
cups, etc.) if not. The energy and nutritional content of
the food consumed was then calculated using the DIAL
software (Alce Ingeniería, 2004). Then, the values
obtained were compared to the recommended dietary
intakes for the Spanish population to determine dietary
adequacy [58].
Body composition
Anthropometric measurements Body height was mea-
sured using a SECA stadiometer (range 80-200 cm,
Valencia, Spain). Body weight (BW) was measured using
a TANITA BC-420MA balance (Bio Lógica Tecnología
Médica S.L, Barcelona, Spain). BMI was calculated as
[body weight (kg)/(height (m))2]. Waist circumference
(WC) was measured using a SECA 201 steel tape
(Quirumed, Valencia, Spain). Body fat percentage was
measured using bioelectrical impedance analysis (BIA)with an OMRON BF 306W analyzer (OMRON HEALTH-
CARE Co., Ltd, Ukyo-ku, Kyoto, Japan).
Dual-energy x-ray absorptiometry Dual-energy x-ray
absorptiometry (DXA) was used to measure percentage
of total fat mass (TFM%), percentage of android fat
(AF%), the android gynoid ratio (A/GF) and lean mass
(kg), using a GE Lunar Prodigy apparatus (GE Healthcare,
Madison, Wisconsin, USA). All DXA scan analyses were
performed at the Faculty of Physical Activity and Sport
Sciences using GE Encore 2002 software v 6.10.029.
Nuclear magnetic resonance Nuclear Magnetic Reson-
ance (MRI) was used to study the proportion and loca-
tion of the adipose tissue. The MRI study measured
changes at different abdominal adipose tissue compart-
ments: SAT (superficial and deep depots) and VAT
(intraperitoneal and retroperitoneal compartments).
Images were obtained with a GE Medical Systems 1.5
Tesla whole body scanner using a T1-weighted fast-spin
echo pulse sequence at the University Hospital La Paz
Research Institute. The subjects were examined in su-
pine position with arms positioned parallel along the lat-
eral sides of the body. The subjects were imaged in two
half-body volumes. A breath-hold sequence during ex-
piration (approximately 20 seconds per acquisition) was
used to minimize the effects of respiratory motion on
the images. The total research time was about 5-10 min.
All images were acquired on a 256x192 matrix, 16 bits/
pixel, with a field of view = 480 mm. Slice thickness was
6 mm and contiguous slices were obtained every 1.5 mm
from de first sacral vertebra upwards, until to achieve 30
images per person. For each subject six reference levels
were studied, corresponding to intervertebral disc levels
L5-S1 to L2-L3, at umbilical and at caudal left kidney
positions. The acquired axial MR images were retrieved
from the scanner using the DICOMW protocol and after
were transferred to an external personal computer run-
ning Windows XP. We used specially designed image
analysis software Stereonauta for quantitative analysis of
the images.
Biochemical, metabolic, inflammatory and genetic profile
Biomarkers Blood samples were taken early in the
morning at the La Paz University Hospital Extraction
Unit after a 12 h overnight fast by venipuncture from
the antecubital vein. Samples were kept at 4- 6°C until
analysis, which was always performed within 48 h fol-
lowing standard hospital procedures. The following
parameters were measured:
 Hematology was performed in a Pentra 120 DX cell
counter (ABX-Horiba, Montpellier, France).
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creatinine, uric acid, bilirrubin, lipase, alkaline
phosphatase, creatinkinase, LDH, GOT and GPT
were analyzed by enzymatic-spectrophotometric
assay (Olympus AU 5400, Izasa, Porto, Portugal).
 Blood lipid profile (total cholesterol, HDL and LDL
cholesterol, triglycerides) and glucose were analyzed
by means of a enzymatic-spectrophotometric assay
(Olympus AU 5400, Izasa, Porto, Portugal). Apo A
and Apo B were determined using a BNII
nephelometer (Siemens Healthcare Diagnostics
GmbH, Eschborn, Germany). Atherogenic risk ratios
were calculated: total cholesterol/HDL, LDL/HDL
and Apo B/Apo A1.
 Plasma fasting inmunoreactive insulin was measured
by enzymatic method in a fluoro-immunochemistry
Analyzer (AIA-360, Tosoh Bioscience, Tessenderlo,
Belgium). Insulin sensitivity was estimated using the
HOMA-IR index [HOMA-IR = fasting glucose
(mmol/l)/fasting immunoreactive insulin
(mU/ml)/22.5].
 Inflammatory biomarkers: Plasma C-reactive protein
concentrations (CRP) were determined using a BNII
nephelometer (Siemens Healthcare Diagnostics
GmbH, Eschborn, Germany). Plasma fibrinogen was
measured by coagulometric methods (ACL TOP
700, Izaasa, Porto, Portugal). Plasma leptin, IL-6 and
TNF-α plasma concentrations were determined
using a LuminexW-LX200 Analyzer (Millipore Corp,
Billerica, Massachusetts, USA) and a MILLIPLEX
MAP human circulating cancer biomarker magnetic
bead panel (HCCBP1MAG-58 K) (Millipore, St.
Charles, Missouri, USA). All samples were analyzed
in duplicate. Data were analyzed using 3.1
xPONENT Software (Millipore, St. Charles,
Missouri, USA). The intra and inter-assay
coefficients of variation for the cytokine assays all
fell in the 5-10% range.
 25-hydroxyvitamin D was measured by
chemiluminescent immunoassay using the
LIAISON” Analyzer family (Palex Medical,
Barcelona, Spain).
 Serum TSH was measured by an
electrochemiluminescence immunoassay (ECLIA) by
using an E170 analyser (Roche Diagnostics,
Mannheim, Germany).Genetic profile We investigated the potential influence
of different genetic single nucleotide polymorphisms
(SNPs), highly prevalent in the general population, on
the response to different training protocols in over-
weight and obesity treatment. These SNPs are located in
genes involved in metabolic pathways related to adiposity(Beta-Adrenergic and Leptin receptors, and Peroxisome
Proliferator-Activated Receptor), and in genes involved
in energy metabolism and the production of energy
during physical activity (metabolism of lactate and fatty
acids). In addition, we have studied the Angiotensin-
Converting Enzyme (ACE) Insertion/Deletion (I/D) poly-
morphism, which has been associated with athletic
performance and training adaptation. The potential
role for most of the selected polymorphisms is well
documented, both as overweight/obesity risk factors and
as modulators for the response to different interventions.
With regard to the method used, we firstly reviewed
published literature about the techniques for analyzing
the polymorphisms [59-68]. Then, we adapted these pro-
tocols to the conditions in our laboratory. Whole blood
(5 ml) from each patient was collected in EDTA and
sent to the Metabolism, Genetics and Nutrition Research
Group of the School of Medicine-IFIMAV, in Santander.
DNA was extracted from each sample using the
“QIAampW DNA Blood Mini Kit” from QIAGEN (Hil-
den, Germany) and the genotyping was performed for
each SNP afterwards. The DNA samples were preserved
at −40°C. All subjects signed a specific informed consent
which allows storage and genetic characterization in re-
lation to the objectives of the PRONAF study by the Me-
tabolism, Genetics and Nutrition Research Group of the
IFIMAV following the protocols of confidentiality and
clinical safety, ensuring the anonymity of the samples
and their use for research only.
After selecting the most interesting SNPs for the pro-
ject objectives, the analyses were performed using geno-
typing assays based on techniques of double PCR, PCR
and RFLP or sequencing for Phase II, and real-time PCR
(TaqManW SNP Genotyping Assays, Applied Biosystem)
for Phase III, which allows the semi-automation of these
determinations. All these techniques proved to be repro-
ducible and stable under the conditions of the study.
The reliability of the techniques used for genotyping in
the different phases of the study has been proved using
internal quality controls through different methods:
repeated measurements of randomized samples, double-
blinded reading of random samples, introduction of
positive and negative controls, and random doubled test-
ing of samples by both techniques. We obtained consist-
ent results for any of the techniques used.Assessment during the follow-up
Training control
Feedbacks for training loads were done once a month
with the Rate of Perceived Exertion (RPE) to subjectively
evaluate each session and determine where the partici-
pant considered the intensity to be at, following a similar
methodology previously used [69].
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PA was assessed as described above once a month. All
subjects were instructed to continue their habitual daily
activities as before the intervention period and were
provided with a PA diary to log the type, duration,
and intensity of any PA or exercise undertaken during
the intervention.Body weight control
BW was measured as described earlier every fifteen days
at the Sports Center. Subjects included in group C used
their own scales to monitor BW at home during the
intervention.Dietary intake control
A dietician interviewed each participant at baseline, and
at 3 and 6 months after the start of the intervention. All
subjects were instructed about how to record their diet-
ary intake using a daily log, and given recommended
portion sizes and information on possible food swaps. In
addition, voluntary group nutrition education sessions
were given by the dieticians. The goal was to equip the
participants with the necessary knowledge and skills to
achieve gradual, permanent behavioural changes.
Statistical analysis
The main independent variables of the study were: inter-
vention group, age, gender, measurement (baseline –
post) and BMI classification (overweight or obese). The
delta percentage was calculated thought the standard
formula: change (%) = [(post-test score − pre-test score)/
pre-test score]*100. The power calculated previously to
find significant differences between groups was 0.8 to fat
mass (%).
Standard statistical methods will be used for the calcu-
lation of the means and standard deviation for all
dependent variables. The statistical analysis will be as
follows: 1) Univariate descriptive analysis, study of data
distribution, basic statistics such as central and dis-
persion values. Pair comparison tests with previous
analysis of the homogeneity of variance will be used.
Pearson correlation coefficients, chi-squared tests and
exact probability calculations will be also performed to
study the relationship between quantitative and qualita-
tive variables, respectively; 2) General lineal models, such
a multivariate analysis (MANOVA) or two way analysis
of variance (ANOVA) for repeated measures, will be used
to determine differences among the four interventions
groups and between baseline and post-training values.
Compound symmetry, or sphericity, will be verified by
the Mauchly test. When the assumption of sphericity
would not be met, the significance of F ratios will be
adjusted according to the Greenhouse-Geisser procedure.Multiple comparisons of ANOVAs will be made with the
Bonferroni post -hoc test.
The analysis of the data will be done using statistical
package SPSS (SPSS Inc., Chicago, Illinois, USA). The
significant level will be set at α = 0.05.
Assessment for quality control
Previous to the start of the intervention we developed a
protocol book with all the tests carried out in the pre
and post intervention, plus the intervention procedures.
An external observer followed the pilot study and his
observations were included in the protocols. Weekly
meetings during the pilot study were made with all the
people involved in the project to train them and perform
the protocol book.
At the end of the overweight intervention, the subjects
filled in a satisfaction questionnaire. The results were
included in the design of the obese intervention.
Finally, in order to clean the final data base of possible
errors, a double data entry procedure was performed.
Also an assessment of missing data and the identifica-
tion of potential outliers were carried out.
Discussion
The PRONAF study is the first randomized controlled
intervention study performed in Spanish overweight and
obese adults without any other associated disease with
the aim of losing weight and improving several health-
related parameters by means of combining caloric re-
striction and controlled training programs. One of the
strengths of the PRONAF study is the multidisciplinary
approach. A group of professionals and researchers with
expertise in a specific field: physical activity and fitness,
nutrition, body composition, genetics and biochemical
markers have designed together the study protocols after
an in-depth review of the state of the art in the literature
[8-40]. Exercise protocols were tested in healthy subjects
and study protocols harmonized in a pilot study [70,71].
The PRONAF study has both strengths and limita-
tions. The main limitation is that the study did not in-
clude psychological control of the subjects. During the
study and in the final questionnaire evaluation the sub-
jects pointed out the need of some psychological support
especially when the body weight changes were not so
evident.
On the other hand, the PRONAF study has also sev-
eral strengths: 1) the final sample size of our study was
maintained according to the sample size estimation,
keeping a low dropout rate similar to other studies
[37,40,41]. It is important to note that there were no dif-
ferences between groups in the number of dropouts. 2)
During the training sessions the participants in the study
were continuously monitored by certified trainers to en-
sure the correct execution of the exercises and the
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itional variables as visceral fat, blood lipid profile, and
genotyping broadens the dimension of the PRONAF
study.
In summary, feasibility of the PRONAF protocol has
been proven. Transfer of knowledge is foreseen as a
spin-off, in order that overweight and obese subjects can
benefit from the results. The aim is to transfer it to
sports centers. Effectiveness on individual health-related
parameter will be analyzed in forthcoming publications.
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